Clinical Trial Update: ADD-ON Study to Existing Hypoparathyroidism Studies [Phase 3]

View source ↗

Summary

An update on a Phase 3 ADD-ON clinical trial for hypoparathyroidism sponsored by NIDDK; trial status is not reported in the document.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypoparathyroidism

Snippet

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Conditions: Hypoparathyroidism | Phase 3 | Status: UNKNOWN